We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clearpath Miniprep Colonoscopy Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01374945
Recruitment Status : Withdrawn (Withdrawn for business reasons)
First Posted : June 16, 2011
Last Update Posted : February 27, 2013
Sponsor:
Information provided by:

Study Description
Brief Summary:
Use of Clearpath to facilitate successful completion of colonoscopy procedures with sub-optimal preparation.

Condition or disease Intervention/treatment
Colonoscopy Device: Clearpath Lower GI

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Colonoscopy
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
No Intervention: SOC preparation and colonoscopy
Experimental: Miniprep and Clearpath Device: Clearpath Lower GI
Clearpath device for cleaning of colon by irrigation and evacuation


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  1. Patient 18-70 years
  2. Scheduled for colonoscopy
  3. Providing informed consent

Exclusion Criteria:

  1. Known large polyps (> 2 cm) for polypectomy
  2. Inflammatory Bowel Disease (IBD)
  3. Previous colonic surgery
  4. Known or suspected stricture
  5. Significant co morbidity
  6. Significant diverticular disease
  7. Contraindicated to receive oral Sodium Picosulfate solution
More Information

ClinicalTrials.gov Identifier: NCT01374945     History of Changes
Other Study ID Numbers: EasyGlide-CL-001
First Posted: June 16, 2011    Key Record Dates
Last Update Posted: February 27, 2013
Last Verified: February 2013